FDA Investigator: Debra Emerson

- Debra Emerson first started conducting FDA inspections in 2002, with the last inspection in 2022. Over that time, Debra Emerson has conducted 228 inspections at 180 companies across 191 sites.

Documents

FDA 483 ID Biomedical Corporation of Quebec, Quebec | 2022

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Emergent BioSolutions Canada Inc., Winnipeg | 2022

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 LFB USA, Inc., Charlton | 2022

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 CSL Behring GmbH, Marburg | 2022

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Catalent Maryland, Inc., Harmans | 2021

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Lonza Biologics, Inc., Portsmouth | 2021

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Therapure Biopharma Inc, Mississauga | 2020

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Rentschler Biopharma Inc., Milford | 2019

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 MassBiologics, Boston | 2019

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Biovex Incorporated, Woburn | 2019

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Glaxosmithkline, Wavre | 2019

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 GlaxoSmithKline Biologicals SA, Rixensart | 2019

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Charles River Laboratories, Inc. DBA Charles River, Endosafe, Charleston | 2019

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna | 2019

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 SmartPractice Denmark ApS, Hillerod | 2019

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Cangene BioPharma, LLC dba Emergent BioSolutions, Rockville | 2019

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Sanofi Pasteur, Neuville Sur Saone | 2018

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Sanofi Pasteur, Val De Reuil | 2018

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Associates of Cape Cod, Inc., East Falmouth | 2018

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Cangene BioPharma, LLC, Baltimore | 2018

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 AbbVie Bioresearch Center, Inc., Worcester | 2018

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Ortho-Clinical Diagnostics, Inc., Raritan | 2018

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 OKC Allergy Supplies, Inc., Oklahoma City | 2018

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Emergent Product Development Gaithersburg, Canton | 2017

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Novartis Pharma Stein AG, Stein Ag | 2017

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Baxalta Manufacturing Sarl, Neuchatel | 2017

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 MassBiologics, Boston | 2017

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Octapharma AB, Stockholm | 2016

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Pharming Technologies Bv, Leiden | 2016

Out-of-stock
Debra Emerson
Human Drug Form 483

FDA 483 Sanofi Chimie, Aramon | 2016

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Genzyme Polyclonals S.A.S., Lyon | 2016

Out-of-stock
Debra Emerson
Biologic Form 483

FDA 483 Sanofi Winthrop Industrie, Le Trait | 2016

Out-of-stock
Debra Emerson
Biologic Form 483

Co-Investigators (84)